Browse > Article

Antiproliferative Effect of Chungjogupae-tang Treatment was Associated with the Inhibition of Prostaglandin E2 Release in Human Lung Carcinoma Cells  

Im, Jae-Hyung (Deparktment of Internal Medicine, Dongeui University College of Oriental Medicine)
Kim, Hoon (Deparktment of Medical History, Dongeui University College of Oriental Medicine)
Byun, Mi-Kyeon (Deparktment of Internal Medicine, Dongeui University College of Oriental Medicine)
Kam, Chul-Woo (Deparktment of Internal Medicine, Dongeui University College of Oriental Medicine)
Park, Dong-Il (Deparktment of Internal Medicine, Dongeui University College of Oriental Medicine)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.20, no.4, 2006 , pp. 966-972 More about this Journal
Abstract
The effect of water extract of Chungjogupae-tang (CJGPT) was investigated _on the growth of human lung carcinoma A549 cells. Methods: MTT assay and fluorescent microscope peformed to compare and examine the efficacy of CJGPT treatment on the cytostaticity of lung cancer cells in proportion to time and doses, and DAPI staining and Western blot analysis were used to examine their effect on apoptosis. In addition, the quantitative RT-PCR was used to examine to lung cancer cells growth, and Prostaglandin E2 activity were measured. Results: Exposure of A549 cells to CJGPT respited in the growth inhibition and apoptosis in a dose-dependent manner as measured by MTT assay and fluorescent microscope. The antiproliferative effect by CJGPT treatment in A549 cells was associated with morphological changes such as membrane shrinking and cell rounding up. CJGPT treatment resulted in an up-regulation of cyclin-dependent kinase inhibitor p21 (WAFl/CIPl) in a p53-independent fashion. We found that CJGPT treatment decreased the levels of cyclooxygenase (COX)-2 and inducible nitric oxide synthease (iNOS) expression without significant changes in the expression of COX-1 , which was correlated with a decrease in prostaglandin E2 (PGE2) synthesis. Conclusion: These findings suggested that CJGPT-induced inhibition of human lung carcinoma A549 cell growth was connected with the induction of apoptotic cell death and the results provided important new insights into the possible molecular mechanisms of the anti-cancer activity of CJGPT.
Keywords
Chumgjogupae-tang(CJGPT); Lung carcinoma; Prostaglandin E2; MTT; DAPI;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Park, D.I, Lee, J.H., Moon, S.K., Kim, C.H., Lee, Y.T., Cheong, J., Choi, B.T. and Choi, Y.H. Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiflorum in human lung carcinoma cells, Pharmacol. Res, 51:437-443, 2005   DOI   ScienceOn
2 Zeng, Y.X. and El-Deiry, W.S. Regulation of p21WAF1/CIP1 expression by p53-independent pathways, Oncogene 12:1557-1564, 1996
3 Choi, Y.H., Lee, W.H., Park, K.Y. and Zhang, L. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells, Jpn. J. Cancer Res. 91:164-173, 2000   DOI
4 Tchou, W.W., Rom, W.N. and Tchou-Wong, K.M. Novel form of p21 (WAF1/CIP1/SDI1) protein in phorbol ester-induced G2/M arrest, J. Biol. Chem. 271:29556-29560, 1996   DOI   ScienceOn
5 Giercksky, K.E. COX-2 inhibition and prevention of cancer, Best Pract. Res. Clin. Gastroenterol. 15:821-833, 2001   DOI
6 Dempke, W., Rie, C., Grothey, A. and Schmoll, H.J. Cyclooxygenase-2: a novel target for cancer chemotherapy?, J. Cancer Res. Clin. Oncol. 127:411-417, 2001   DOI   ScienceOn
7 윤창열, 김용진, 난경연구집성, 주민출판사, 서울, pp 768-769, 2002
8 Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D. p21 is a universal inhibitor of cyclin kinases, Nature 366:701-704, 1993   DOI   ScienceOn
9 Li, Y.. Jenkins, C.W., Nichols, M.A. and Xiong, Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21, Oncogene 9:2261-2268, 1994
10 Thun, M.J., Henley, S.J. and Patrono, C. Nonsteroidal anti- inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues, J. Natl. Cancer Inst. 94:252-266, 2002   DOI   ScienceOn
11 Vainio, H. Is COX-2 inhibition a panacea for cancer prevention?, Int. J. Cancer 94:613-614, 2001   DOI   ScienceOn
12 Surh, Y.J., Chun, K.S., Cha, H.H., Han, S.S., Keum, Y.S., Park, K.K. and Lee, S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-$_{\kappa}B$B activation, Mutat. Res. 480-481:243-268, 2001   DOI
13 全國韓醫科大學 肺系內科學敎室, 東醫肺系內科學 12版, 한문문화사, 서울, p 392, 2002
14 Musgrove, E.A., Davison, E.A. and Ormandy, C.J. Role of the CDK Inhibitor p27 (Kip1) in mammary development and carcinogenesis: Insights from knockout mice, J. Mammary Gland Biol. Neoplasia 9:55-66, 2004   DOI   ScienceOn
15 Sawaoka, H., Tsuji, S., Tsujii, M., Gunawan, E.S., Sasaki, Y., Kawano, S. and Hori, M. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo, Lab. Invest. 79:1469-1477, 1999
16 吳 謙, 醫宗金鑑, 중국중의학출판사, 북경, p 500, 1995
17 Datto, M.B., Yu, Y. and Wang, X.F. Functional analysis of the transforming growth factor $\beta$ responsive elements in the WAF1/Cip1/p21 promoter, J. Biol. Chem, 270:28623-28628, 1995   DOI
18 Taylor, W.R. and G.R. Stark, 2001 Regulation of the G2/M transition by p53, Oncogene 20:1803-1815, 2001   DOI   ScienceOn
19 통계청, 2001년 사망원인통계결과, p 11, 2002
20 許 俊, 東醫寶鑑, 법인문화사, 서울, p 1433, 1996
21 Harper, J.W. Cyclin dependent kinase inhibitors, Cancer Surv. 29:91-107, 1997
22 박재갑, 인간생명과학, 서울대학출판부, 서울, p 392, 394, 1994
23 Yamamoto, Y. and Gaynor, R.B. Therapeutic potential of inhibition of the NF-$_{\kappa}B$B pathway in the treatment of inflammation and cancer, J. Clin. Invest. 107:135-142, 2001   DOI   ScienceOn
24 Dulic, V., Stein, G.H., Far, D.F. and Reed, S.I. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition, Mol. Cell Biol. 18:546-557, 1998.   DOI